Purpura, Thrombotic Thrombocytopenic - 18 Studies Found

Withdrawn : Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
: Purpura, Thrombotic Thrombocytopenic
: 2012-12-12
:
  • Drug: Octaplas infusion and placebo (group 1)

Terminated : IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
: Purpura, Thrombotic Thrombocytopenic
: 2016-07-27
: Biological: HMed-IdeS One dose of 0.25 mg/kg BW HMed-IdeS on study day 0. Following and evaluation of ef
Completed : Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
: Thrombotic Thrombocytopenic Purpura
: 2009-05-22
: Drug: rituximab Patients will be treated according to the recommendations of the Reference Centre for th
Active, not recruiting : Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
: Thrombotic Thrombocytopenic Purpura
: 2008-07-09
:
  • Drug: Cyclosporine 2-3 mg/kg o
Completed : Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
: Thrombotic Thrombocytopenic Purpura
: 2010-06-25
:
  • Biological: anti-vWF Nanobody

Recruiting : Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
: Acquired Thrombotic Thrombocytopenic Purpura
: 2015-09-14
:
  • Biological: caplacizumab Other
Recruiting : The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
: Thrombotic Thrombocytopenic Purpura (TTP)
: 2009-07-09
: Drug: Rituximab Concentrate for solution for infusion, Intravenous use, 375mg/m2, Maximum 8 weekly infus
Terminated : Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
: Thrombotic Thrombocytopenic Purpura (TTP)
: 2006-12-13
:
  • Biological: Uniplas Uniplas wi
Completed : Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
: Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
: 2014-08-12
: Drug: Recombinant ADAMTS13 rADAMTS13 (a disintegrin and me
Recruiting : Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
: Thrombotic Thrombocytopenic Purpura
: 2012-03-08
: Biological: rituximab rituximab intravenously 100 mg every week for four doses
Next >>>